Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 2,767 $ 5,672
Short-term investments 15,206 10,836
Prepaid expenses and other current assets 48 54
Total Current Assets 18,021 16,562
Operating lease right-of-use asset 114 165
Deposits 9 9
TOTAL ASSETS 18,144 16,736
Current liabilities    
Accounts payable 3,501 3,140
Accrued expenses 1,222 1,669
Current operating lease liability 120 110
Total Current Liabilities 4,843 4,919
Non-current operating lease liability 64
Warrant liability 1,538 19
Total Liabilities 6,381 5,002
Stockholders’ Equity    
Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 1 1
Common stock, par value $0.001, 250,000,000 shares authorized, 40,639,688 shares and 32,722,452 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 41 33
Additional paid in capital 688,408 686,168
Accumulated deficit (676,687) (674,468)
Total Stockholders’ Equity 11,763 11,734
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 18,144 $ 16,736